Form 8-K - Current report:
SEC Accession No. 0001193125-25-132111
Filing Date
2025-05-30
Accepted
2025-05-30 16:06:00
Documents
13
Period of Report
2025-05-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d908343d8k.htm   iXBRL 8-K 27288
  Complete submission text file 0001193125-25-132111.txt   183379

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA autl-20250523.xsd EX-101.SCH 3698
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE autl-20250523_def.xml EX-101.DEF 14513
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE autl-20250523_lab.xml EX-101.LAB 23778
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE autl-20250523_pre.xml EX-101.PRE 15421
15 EXTRACTED XBRL INSTANCE DOCUMENT d908343d8k_htm.xml XML 6035
Mailing Address THE MEDIAWORKS 191 WOOD LANE LONDON X0 W12 7FP
Business Address THE MEDIAWORKS 191 WOOD LANE LONDON X0 W12 7FP 44 20 3829 6230
Autolus Therapeutics plc (Filer) CIK: 0001730463 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38547 | Film No.: 251010856
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)